Ralph Baric
15Patents
3h-index
34Co-inventors
60Inventor score
Filing activity: May 21, 2001 → Dec 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6593111B2 | Directional assembly of large viral genomes and chromosomes | Chemistry; Metallurgy | 20 | Expired |
| US11225508B1 | Mouse-adapted SARS-CoV-2 viruses and methods of use thereof | Chemistry; Metallurgy | 10 | Active |
| US9884895B2 | Methods and compositions for chimeric coronavirus spike proteins | Chemistry; Metallurgy | 9 | Active |
| US9975923B2 | Methods and compositions for norovirus blockade epitopes | Physics | 1 | Active |
| US10117924B2 | Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions | Emerging Cross-Sectional Technologies | 1 | Active |
| US9821050B2 | Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions | Emerging Cross-Sectional Technologies | 0 | Active |
| US11566050B2 | Methods and compositions for norovirus vaccines and diagnostics | Emerging Cross-Sectional Technologies | 0 | Active |
| US7618802B2 | Compositions of coronaviruses with a recombination-resistant genome | Chemistry; Metallurgy | 0 | Active |
| US7279327B2 | Methods for producing recombinant coronavirus | Chemistry; Metallurgy | 0 | Expired |
| US11241491B2 | Methods and compositions for dengue virus serotype 4 epitopes | Emerging Cross-Sectional Technologies | 0 | Active |
| US11905306B2 | Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of SARS virus | Chemistry; Metallurgy | 0 | Active |
| US10053493B2 | Methods and compositions for dengue virus vaccines | Emerging Cross-Sectional Technologies | 0 | Active |
| US10398768B2 | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development | Emerging Cross-Sectional Technologies | 0 | Active |
| US11492379B2 | SARS-CoV-2 viruses and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US10870682B2 | Methods and compositions for dengue virus vaccines | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.